Canada markets closed

Universe Pharmaceuticals INC (UPC)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.5900+0.0800 (+3.19%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 9.15M
Enterprise Value -3.87M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.28
Price/Book (mrq)0.23
Enterprise Value/Revenue -0.06
Enterprise Value/EBITDA 0.31

Trading Information

Stock Price History

Beta (5Y Monthly) 1.66
52-Week Change 3-37.56%
S&P500 52-Week Change 326.36%
52 Week High 35.8800
52 Week Low 30.7500
50-Day Moving Average 32.0537
200-Day Moving Average 31.6126

Share Statistics

Avg Vol (3 month) 378.51k
Avg Vol (10 day) 329.7k
Shares Outstanding 53.65M
Implied Shares Outstanding 63.65M
Float 81.55M
% Held by Insiders 157.05%
% Held by Institutions 10.08%
Shares Short (Apr 30, 2024) 47.74k
Short Ratio (Apr 30, 2024) 40.07
Short % of Float (Apr 30, 2024) 40.49%
Short % of Shares Outstanding (Apr 30, 2024) 40.21%
Shares Short (prior month Mar 28, 2024) 48.43k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:6
Last Split Date 3Jul 28, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Sept 30, 2023
Most Recent Quarter (mrq)Sept 30, 2023

Profitability

Profit Margin -19.08%
Operating Margin (ttm)-26.56%

Management Effectiveness

Return on Assets (ttm)-3.91%
Return on Equity (ttm)-14.34%

Income Statement

Revenue (ttm)32.31M
Revenue Per Share (ttm)8.91
Quarterly Revenue Growth (yoy)-13.20%
Gross Profit (ttm)N/A
EBITDA -3.02M
Net Income Avi to Common (ttm)-6.16M
Diluted EPS (ttm)-1.7000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)18.5M
Total Cash Per Share (mrq)5.11
Total Debt (mrq)5.48M
Total Debt/Equity (mrq)13.87%
Current Ratio (mrq)2.68
Book Value Per Share (mrq)10.91

Cash Flow Statement

Operating Cash Flow (ttm)1.12M
Levered Free Cash Flow (ttm)1.59M